Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Glucocorticoid-induced tumor necrosis factor receptor (GITR) antibodies and methods of use thereof

Glucocorticoid-induced tumor necrosis factor receptor (GITR) antibodies and methods of use thereof

US Patent 11046777 · Granted Jun 29, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies against MUC12025
Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereof2025
Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereof2025
Engineered cells, T cell immune modulating antibodies and methods for using the 2025
Engineered cells, T cell immune modulating antibodies and methods for using the 2025
Chimeric antigen receptors and methods of use thereof2025
Humanized influenza monoclonal antibodies and methods of use thereof2024
Method of treating a tumor expressing carbonic anhydrase IX (G250) by administer2024
Manufacturing method of thin-film power inductor and thin-film power inductor2024
Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereof2023
Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereof2023
Light fixture with rotatable light source2023